Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis

Turkish Journal of Gastroenterology

Volumn 15, Issue 1, 2004, Pages 34-38

  Taşkiran, Bengür ^a,b   Çolakoǧlu, Önder ^a   Sözmen, Bülent ^a   Ünsal, Belkis ^a   Aslan, Sakine L ^a   Buyraç, Zafer ^a  

^a Izmir Teaching and Research Hospital   (Turkey)

^b Clinics of Gastroenterology ^*  (Turkey)

Author keywords

Ofloxacin; Spontaneous bacterial peritonitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMOXICILLIN; AMOXICILLIN PLUS SULBACTAM; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; CEFEPIME; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DIURETIC AGENT; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; LACTATE DEHYDROGENASE; OFLOXACIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SCREENING; ESCHERICHIA COLI; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; NEPHROTOXICITY; OUTCOMES RESEARCH; OUTPATIENT CARE; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

ADULT; AGED; ANALYSIS OF VARIANCE; CEFOTAXIME; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OFLOXACIN; PERITONITIS; PROBABILITY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 2942593706     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Rimola A. Infections in liver disease. In: McIntyre N, Benham-ou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford University Press, 1991; 1272-84.
2. Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993; 17: 251-7.
3. Rimola A, Salmeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995; 21: 674-9.
4. Runyon BA, McHutchinson JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology 1991; 100: 1737-42.
5. Mihas AA, Toussaint J, Hsu SL, et al. Spontaneous bacterial peritonitis in cirrhosis: clinical and laboratory features, survival and prognostic indicators. Hepatogastroenterology 1992; 39: 520.
6. Hoefs JC, Canawati HN, Sapico FL, et al. Spontaneous bacterial peritonitis. Hepatology 1982; 2: 399.
7. Navasa M, Follo A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996; 111: 1011-7.
8. Terg R, Cobas S, Fassio E, et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol 2000; 33: 564-9.